|
|
|
|
| UK |
 |
|
“Right Care”: Implications for Pharma |
The Lancet's new series of papers on moving from universal health care to "right care" for health offers a global and comprehensive perspective, writes Leela Barham. But what does "right care" mean for the industry?
... /Read more/ |
|
|
|
| Calendar |
|
/ March 29–31, 2017: DIA EuroMeeting 2017 / |
|
Glasgow, UK |
|
/ January 24–25, 2017: 12th Annual Biosimilars Summit / |
|
Alexandria, VA, USA |
|
/ February 22–23, 2017: Speaker Programs 2017 / |
|
Philadelphia, USA |
|
/ March 14–16, 2017: eyeforpharma Barcelona 2017 / |
|
Barcelona, Spain |
|
/ April 26-28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress / |
|
Washington, DC |
|
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada / |
|
Toronto, CA |
|
|
|
| Industry update |
| //Mundipharma International (Cambridge, UK) appointed Susie Hackett as Head of Corporate Communications.//Targovax (Oslo, Noway) appointed Erik Digman Wiklund as Chief Financial Officer. He will take up this role in April 2017.//Asceneuron (Lausanne, Switzerland) appointed J. Michael Ryan, M.D. as Chief Medical Officer. //Albumedix A/S (Copenhagen, Denmark) named Dr. Giles Campion as Chief Medical Officer.//Björn Westberg is to leave his position as CFO of Recipharm (Haninge, Sweden) on February 23, 2017.// |
|
|
|
|
| |
|
|
